Clinical Trial Update: Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated goserelin acetate for ovarian function in women with primary breast cancer; the study was terminated and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2011-07-26